Owning 43% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA), [Yahoo! Finance]
Aura Biosciences, Inc. (AURA)
Company Research
Source: Yahoo! Finance
A total of 7 investors have a majority stake in the company with 52% ownership Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. To get a sense of who is truly in control of Aura Biosciences, Inc. ( NASDAQ:AURA ), it is important to understand the ownership structure of the business. With 43% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Because institutional owners have a huge pool of resources and liquidity, their investing decisions tend to carry a great deal of weight, especially with individual investors. Hence, having a considerable amount of institutional money invested in a
Show less
Read more
Impact Snapshot
Event Time:
AURA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AURA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AURA alerts
High impacting Aura Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
AURA
News
- Aura Biosciences (NASDAQ:AURA) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.MarketBeat
- Aura Biosciences to Participate in the 8th Annual Evercore Healthcare ConferenceGlobeNewswire
- Aura Biosciences: Bringing Not-Quite-Viruses Closer To Fruition In Cancer [Seeking Alpha]Seeking Alpha
- Aura Biosciences GAAP EPS of -$0.40 beats by $0.07 [Seeking Alpha]Seeking Alpha
- Aura Biosciences Reports Third Quarter 2025 Financial Results and Business HighlightsGlobeNewswire
AURA
Earnings
- 11/13/25 - Beat
AURA
Sec Filings
- 11/17/25 - Form 144
- 11/17/25 - Form 4
- 11/13/25 - Form 10-Q
- AURA's page on the SEC website